Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Eun-Young LeeCancer Microenvironment Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0001-7295-8574
June Hyuk KimDepartment of Orthopaedic Surgery, Center for Rare Cancer Center, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0002-8899-5342
Jong Woong ParkDepartment of Orthopaedic Surgery, Center for Rare Cancer Center, National Cancer Center, Goyang 10408, Republic of Korea.
Hyun Guy KangDepartment of Orthopaedic Surgery, Center for Rare Cancer Center, National Cancer Center, Goyang 10408, Republic of Korea.
Seog-Yun ParkDepartment of Pathology, National Cancer Center Hospital, National Cancer Center, Goyang 10408, Republic of Korea.
Jiyu SunDepartment of Public Health and AI, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.
Seo-Young KimBiostatistics Collaboration Team, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0002-8258-0090
Ahyoung ChoCancer Microenvironment Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0009-0007-1128-3295
Bora LeeDepartment of Orthopaedic Surgery, Center for Rare Cancer Center, National Cancer Center, Goyang 10408, Republic of Korea.
Hye Jin YouCancer Microenvironment Branch, Division of Cancer Biology, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.ORCID 0000-0001-5566-5171
Funding
Korea National Institute of Health No.2024-ER0511-01 (to JHKIM)National Cancer Center NCC-2311420 (to HJYOU)National Cancer Center NCC-2410760 (to HJYOU)
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Clinical Characteristics of Complex Karyotype Soft Tissue Sarcomas: A Single-Institution Cohort Study. · full record | OpenQuestion